Epidemiology Department, Komisarenko Institute of Endocrinology and Metabolism, Kyiv 04114, Ukraine.
Endocrinology Department, Shupyk National Medical Academy of Postgraduate Education, Kyiv 04112, Ukraine.
Exp Biol Med (Maywood). 2020 Jul;245(13):1115-1121. doi: 10.1177/1535370220931509. Epub 2020 Jun 9.
Metabolic disorders are known to be associated with accelerated telomere attrition. Their pathophysiological heterogeneity suggests the importance of multiple tests in examining these associations. However, oral glucose tolerance test (OGTT) has rarely been performed in such studies to date. There are few studies aimed at determining leukocyte telomere length (LTL) in different categories of impaired glucose tolerance (IGT), and those that do exist do not take into account the impaired fasting glucose (IFG)/IGT categorization. Therefore, we believe our study, when the OGTT was used, is important to the field. This testing made it possible to determine whether LTLs are associated with glucose levels in different hyperglycemic categories. Our data indicate that relationships between LTLs and IFG/IGT levels are not the same. This distinction can potentially be used in categorization of metabolic disorders and in determining the effectiveness of interventions aimed at treating diabetes and other metabolic abnormalities.
代谢紊乱与端粒加速损耗有关,这是众所周知的。它们的病理生理异质性表明,在研究这些关联时,需要进行多项检查。然而,到目前为止,此类研究中很少进行口服葡萄糖耐量试验(OGTT)。关于不同类型糖耐量受损(IGT)的白细胞端粒长度(LTL)的研究很少,而且现有的研究也没有考虑到空腹血糖受损(IFG)/IGT 的分类。因此,我们认为,当使用 OGTT 时,我们的研究对该领域很重要。这种检测使我们能够确定 LTL 是否与不同高血糖类别中的血糖水平相关。我们的数据表明,LTL 与 IFG/IGT 水平之间的关系并不相同。这种区别可潜在地用于代谢紊乱的分类,并确定旨在治疗糖尿病和其他代谢异常的干预措施的有效性。